• 1
    Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985–1996. J Am Acad Dermatol 2001; 45: 52836.
  • 2
    Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 1999; 81: 5559.
  • 3
    Karagas MR, Stukel TA, Greenberg ER, Baron JA, Mott LA, Stern RS. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. JAMA 1992; 267: 330510.
  • 4
    Robinson J. Risk of developing another basal cell carcinoma: a 5-year prospective study. Cancer 1987; 60: 11820.
  • 5
    Richmond-Sinclair NM, Pandeya N, Ware RS, Neale RE, Williams GM, van der Pols JC, Green AC. Incidence of basal cell carcinoma multiplicity and detailed anatomic distribution: longitudinal study of an Australian population. J Invest Dermatol 2009; 129: 3238.
  • 6
    Chen JG, Fleischer AB, Jr, Smith ED, Kancler C, Goldman ND, Williford PM, Feldman SR. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg 2001; 27: 10358.
  • 7
    Morris S, Cox B, Bosanquet N. Cost of skin cancer in England. London: Tanaka Business School, Imperial College of London, 2005.
  • 8
    AIHW. Health system expenditures on cancer and other neoplasms in Australia, 2000–01. AIHW cat. no. HWE 29. Canberra: Australian Institute of Health and Welfare, 2005.
  • 9
    van Iersel CA, van de Velden HV, Kusters CD, Spauwen PH, Blokx WA, Kiemeney LA, Gerritsen MJ. Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up. Br J Dermatol 2005; 153: 107880.
  • 10
    Tangrea J, Edwards B, Taylor P, Hartman A, Peck G, Salasche S, Menon P, Benson P, Mellette J, Guill M, Robinson J, Guin J, et al. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. J Natl Cancer Inst 1992; 84: 32832.
  • 11
    Ramachandran S, Lear JT, Ramsay H, Smith AG, Bowers B, Hutchinson PE, Jones PW, Fryer AA, Strange RC. Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype. Cancer Epidemiol Biomarkers Prev 1999; 8: 617.
  • 12
    Lovatt TJ, Lear JT, Bastrilles J, Wong C, Griffiths CE, Samarasinghe V, Roebuck J, Ramachandran S, Smith AG, Jones PW, Fryer AA, Strange RC. Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors. J Am Acad Dermatol 2005; 52: 46873.
  • 13
    Ghissassi F, Baan R, Straif K, Grosse Y, Secretan B, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens—part D: radiation. Lancet Oncol 2009; 10: 7512.
  • 14
    Lovatt TJ, Lear JT, Bastrilles J, Wong C, Griffiths CE, Ramachandran S, Smith AG, Salim A, Fryer AA, Jones PW, Strange RC. Associations between UVR exposure and basal cell carcinoma site and histology. Cancer Lett 2004; 216: 1917.
  • 15
    Neale RE, Davis M, Pandeya N, Whiteman DC, Green AC. Basal cell carcinoma on the trunk is associated with excessive sun exposure. J Am Acad Dermatol 2007; 56: 3806.
  • 16
    Ramachandran S, Fryer AA, Smith A, Lear J, Bowers B, Jones PW, Strange RC. Cutaneous basal cell carcinomas: distinct host factors are associated with the development of tumors on the trunk and on the head and neck. Cancer 2001; 92: 3548.
  • 17
    Marghoob A, Kopf AW, Bart RS, Sanfilippo L, Silverman MK, Lee P, Levy E, Vossaert KA, Yadav S, Abadir M. Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma. J Am Acad Dermatol 1993; 28: 228.
  • 18
    Green A, Beardmore G, Hart V, Leslie D, Marks R, Staines D. Skin cancer in a Queensland population. J Am Acad Dermatol 1988; 19: 104552.
  • 19
    Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, Marks GC, Gaffney P, Battistutta D, Frost C, Lang C, Russell A. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999; 354: 7239.
  • 20
    van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 2006; 15: 25468.
  • 21
    Van der Pols JC, Williams GM, Neale RE, Clavarino A, Green AC. Long-term increase in sunscreen use in an Australian community after a skin cancer prevention trial. Prev Med 2006; 42: 1716.
  • 22
    Green A, Battistutta D, Hart V, Leslie D, Weedon D. Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour Study Group. Am J Epidemiol 1996; 144: 103440.
  • 23
    Kricker A, Armstrong BK, English DR, Heenan PJ. Pigmentary and cutaneous risk factors for non-melanocytic skin cancer—a case-control study. Int J Cancer 1991; 48: 65062.
  • 24
    Naldi L, DiLandro A, D'Avanzo B, Parazzini F. Host-related and environmental risk factors for cutaneous basal cell carcinoma: evidence from an Italian case-control study. J Am Acad Dermatol 2000; 42: 44652.
  • 25
    Marks R. Solar keratoses. Br J Dermatol 1990; 122 ( Suppl 35): 4954.
  • 26
    Rossi R, Mori M, Lotti T. Actinic keratosis. Int J Dermatol 2007; 46: 895904.
  • 27
    Shoveller J, Lovato C. Measuring self-reported sunburn: challenges and recommendations. Chronic Dis Can 2001; 22: 7587.